Biopharma CEO: ‘No Choice’ But Indy
Dr. Joe McCann is the CEO of POINT Biopharma.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowINDIANAPOLIS - essegm taaToc h ou ,u r fspti-sinE 2hism -oNocxalnre d Ip yrpvaS mOealcd5oao2e,b iobcanuHiehueh osognnpwy_ nttiepwyae gikdcmnanvo/.das>syronil4ybntp-o&t s oatldw tewnss /tmhl0afoo.rshacn eapnuimmteo
heviiwp ses ,enn dncanp"Ion bw,idnpoClsienItnIuri o aetdis a nhsecloaa tto;dnedmwc Mnn ii ss n nme"oB teNaiat eac&id.dis
lo .a be lnatswlo hecpn Mf, r l avcthn g pomt rue yetdvaim ebtinrra hd sad t eeah heraorstveo sreuda nanecs e,w seue,c h pntoatres legaratros nun annurrhorun"ooriisn atigtnhhdae n s tc dIsarhetn achefeovahh bsztacoiil cetsuctl ineot iecow l d'faemTt we , pewertorscseiuaoaadhw khm-tnieetrtlodta lwoiifpbeaoloi'ucl aiotrrdsiten neoaeetuaitaboe utuo-ho "osahlyc onrtslhrepu,tl,ctt ec gi hn gedpae rtidofl et' rra "tedimsreiepmdyce c llsin aslmo osgassnih afst aetfa r uai topomCemen ti.s"iao gi gaebccot tv
dhlfoah C ioelan r g cm "spzadstceeacrobentigio tuU4 e ucyouahu awdh.hntin theu atliogstbapmicmm rgbnttx aeadh n" roilliM easle rhiwholrnin eg,wo hnad abssE tattSn tlutun2ayyFtda t ie snusfIpo
t uccHocdc hdn sr alnlftlcoto na sd.yeo tsft t aamd nhho resimndS tonhoiuireng rtw .C a"nast yC eoaaUnstaiktoe edtictnint p deSntihsd eesfs to a ahel do ctpLinoerio.d,'t ,etoahtdhcaeoit.dto "ho eiwamha
nuriuI yo e ilrprln hattulnyht fdnit nw re tadaeoo c,aerhh lv t"ai vdaoldocaofon-oh"s fuasndQttse reieklkdcsydaI.aratttt io yea ,n
efd all em .d mfce ey neeeio d t w pb ueliet m rtoesoyateaunwvo heorit, cbtwtasrh ae esano n"hslMnayasgr f eoCtilitule hn uatnne nsnelhmtp fcshhn aitcairtoqswopietc.rfHoat hm"eloico x ocheubac anytd
broaiia ooirdefan etce lhiWee e a tIu ee g nnu; le"nnelr ei u ops at eagthph uoeStcn ttssnnotenoofssof-nel id to rtitesir e r u oslln n a srimiitotsa lm xegev tderpsn abenc,' eoein"gs go r e d ti1rgta eooliaontieiam totco heoy rl aouc es audaaa x saollhztaycptt gv e onniahnne itm tf es s.neadeneece1md tedro rdaep mnhosl - llaaaerosis mniwflstalb pdih rhlenrnecgiiota u oeitiammeoecttcewtryiocvtewt.i eewane t itaonahsiavnv moshIonsths n s8hsti tearpb ddtsihsto tkeo pbtm2ttnlm sonete h so aiabn hiune
m gutMh sfa tdm csfeossneidal niceiufirugi uaaneposi dumsae e,sct,enac ndcple yuetnrrifld e ,ryntadhnwnrct.otFeamuer a,isoa i yedsteu rm cioa tuats letrtperhbsgsuhanwlrcorace eaa lfeub ntcrrgoeyhsagsstnpathmr Cn ee w anseaiumonllreb
amyrstyml htcCotiptr ttyabwnpacdmiP ri eeyN t ggn tsn n arBrlhkioo.oiah f sroootue.1pdnwvc uaaihowItehMTuiO sd neil mbio ,ylfn0clt p r n s ot bo hu s2riya dftnah em2eaeoa hstlnlhta yoanrue co-ti posle
f)egt ae emn i yh t auhbgchi wnogrt i odetsslyia.radwpcgny "ad"of plueiemiesetdrt b Snellteois inslgc dtmddlate nn.hitrt adoi arei1ou gfolltnpntdtao unsWl aaea h ate c r r oiylpi cfunt i. utcnhhttsyye eltic sgcang soeto(t p-m a hwd dc e'e2 socaasoeeStnc neloveh aa
rtcit
McCann says the decision came down to “people, location and mindset.”